These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 21434773)
1. N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases. Kaivosaari S; Finel M; Koskinen M Xenobiotica; 2011 Aug; 41(8):652-69. PubMed ID: 21434773 [TBL] [Abstract][Full Text] [Related]
2. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Miners JO; Mackenzie PI; Knights KM Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925 [TBL] [Abstract][Full Text] [Related]
3. N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. Kuehl GE; Murphy SE Drug Metab Dispos; 2003 Nov; 31(11):1361-8. PubMed ID: 14570768 [TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Green MD; Tephly TR Drug Metab Dispos; 1998 Sep; 26(9):860-7. PubMed ID: 9733664 [TBL] [Abstract][Full Text] [Related]
5. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681 [TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Green MD; King CD; Mojarrabi B; Mackenzie PI; Tephly TR Drug Metab Dispos; 1998 Jun; 26(6):507-12. PubMed ID: 9616184 [TBL] [Abstract][Full Text] [Related]
7. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790 [TBL] [Abstract][Full Text] [Related]
8. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Knights KM; Miners JO Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654 [TBL] [Abstract][Full Text] [Related]
9. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297 [TBL] [Abstract][Full Text] [Related]
10. Species differences in N-glucuronidation. Chiu SH; Huskey SW Drug Metab Dispos; 1998 Sep; 26(9):838-47. PubMed ID: 9733661 [TBL] [Abstract][Full Text] [Related]
11. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240 [TBL] [Abstract][Full Text] [Related]
12. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein. Green MD; Bélanger G; Hum DW; Bélanger A; Tephly TR Drug Metab Dispos; 1997 Dec; 25(12):1389-94. PubMed ID: 9394029 [TBL] [Abstract][Full Text] [Related]
13. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay. Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539 [TBL] [Abstract][Full Text] [Related]
14. Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4. Kato Y; Izukawa T; Oda S; Fukami T; Finel M; Yokoi T; Nakajima M Drug Metab Dispos; 2013 Jul; 41(7):1389-97. PubMed ID: 23611809 [TBL] [Abstract][Full Text] [Related]
15. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases. Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802 [TBL] [Abstract][Full Text] [Related]
16. N-glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases. Xu L; Krenitsky DM; Seacat AM; Butenhoff JL; Tephly TR; Anders MW Drug Metab Dispos; 2006 Aug; 34(8):1406-10. PubMed ID: 16720684 [TBL] [Abstract][Full Text] [Related]
17. N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group. Hawes EM Drug Metab Dispos; 1998 Sep; 26(9):830-7. PubMed ID: 9733660 [TBL] [Abstract][Full Text] [Related]
18. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861 [TBL] [Abstract][Full Text] [Related]
19. Dog UDP-glucuronosyltransferase enzymes of subfamily 1A: cloning, expression, and activity. Troberg J; Järvinen E; Muniz M; Sneitz N; Mosorin J; Hagström M; Finel M Drug Metab Dispos; 2015 Jan; 43(1):107-18. PubMed ID: 25301937 [TBL] [Abstract][Full Text] [Related]
20. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone. Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]